<DOC>
	<DOCNO>NCT00854529</DOCNO>
	<brief_summary>Trabeculectomy ocular surgery intend reduce intra-ocular pressure surgery create sub-conjunctival filter bleb filter aqueous humor fluid . A rather common adverse event surgery increase vascularity conjunctiva overlie bleb . This lead adherence conjunctiva sclera fibrosis finally failure bleb ( surgery ) study intend demonstrate post operative subconjunctival bevacizumab injection reduce incidence bleb vascularity ultimately , bleb failure .</brief_summary>
	<brief_title>Subconjunctival Bevacizumab Effect Bleb Vascularity</brief_title>
	<detailed_description>trabeculectomy ocular surgery intend reduce intra-ocular pressure surgery create sub-conjunctival filter bleb filter aqueous humor fluid . rather common adverse event surgery increase vascularity conjunctiva overlie bleb . lead adherence conjunctiva sclera fibrosis finally failure bleb ( surgery ) study wish demonstrate post operative subconjunctival bevacizumab injection reduce incidence bleb vascularity ultimately , bleb failure . study , one study group give subconjunctival bevacizumab 1 week surgery , another study group give subconjunctival bevacizumab 2 week surgery , third group serve control receive bevacizumab . bleb vascularity diagnose patient treat accord current guideline .</detailed_description>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Mitomycin</mesh_term>
	<mesh_term>Mitomycins</mesh_term>
	<criteria>post uneventful trabeculectomy mitomycin c application surgery adult usage 5fluorouracil trabeculectomy postoperative complication ischemic heart disease s/p cerebrovascular accident allergy bevacizumab</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>bevacizumab</keyword>
	<keyword>subconjunctival injection</keyword>
	<keyword>trabeculectomy</keyword>
	<keyword>bleb</keyword>
	<keyword>mitomycin c</keyword>
</DOC>